My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
RES-2022-168
>
Meetings
>
2022
>
09. September
>
2022-09-06 10:00 AM - Commissioners' Agenda
>
RES-2022-168
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
9/13/2022 11:54:56 AM
Creation date
9/13/2022 11:53:49 AM
Metadata
Fields
Template:
Meeting
Date
9/6/2022
Meeting title
Commissioners' Agenda
Location
Commissioners' Auditorium
Address
205 West 5th Room 109 - Ellensburg
Meeting type
Regular
Meeting document type
Fully Executed Version
Supplemental fields
Item
Request to Approve a Resolution Authorizing the Chair's Signature on a Opioid Litigation Allocation Agreement
Order
3
Placement
Consent Agenda
Row ID
93293
Type
Agreement
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
107
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
4. Provide evidence-informed treatment, including MAT, recovery support, or other <br />appropriate services to individuals with OUD and any co-occurring SUD/MH <br />conditions, co-usage, and/or co-addiction who are incarcerated in jail or prison. <br />5. Provide evidence-informed treatment, including MAT, recovery support, or other <br />appropriate services to individuals with OUD and any co-occurring SUD/MH <br />conditions, co-usage, andlor co-addiction who are leaving jail or prison have recently <br />left jail or prison, are on probation or parole, are under community corrections <br />supervision, or are in re-entry programs or facilities. <br />6. Support critical time interventions (CTI), particularly for individuals living with dual- <br />diagnosis OUD/serious mental illness, and services for individuals who face <br />immediate risks and service needs and risks upon release from correctional settings. <br />7. Provide training on best practices for addressing the needs of criminal-justice- <br />involved persons with OUD and any co-occurring SUD/MH conditions, co-usage, <br />andlor co-addiction to law enforcement, correctional, or judicial personnel or to <br />providers of treatment, recovery, case management, or other services offered in <br />connection with any of the strategies described in this section. <br />E.ADDRE SS THE NEEDS OF' PREGNANT OR PARE G WOMEN AND <br />THEIR FAMILIES. INCI,IIDING RA WITH NEONATAL ABSTINENCE. <br />SYNDROME <br />Address the needs of pregnant or parenting women with OUD and any co-occurring <br />SUD/MH conditions, co-usage, and/or co-addiction, and the needs of their families, including <br />babies with neonatal abstinence syndrome, through evidence-based, evidence-informed, or <br />promising programs or strategies that may include, but are not limited to, the following: <br />1. Support evidence-based, evidence-informed, or promising treatment, including MAT, <br />recovery services and supports, and prevention services for pregnant women - or <br />women who could become pregnant - who have OUD and any co-occurring SUD/MH <br />conditions, co-usage, and/or co-addiction, and other measures to educate and provide <br />support to families affected by Neonatal Abstinence Syndrome. <br />2. Provide training for obstetricians or other healthcare personnel that work with <br />pregnant women and their families regarding treatment of OUD and any co-occurring <br />SUD/MH conditions, co-usage, andl or co-addiction. <br />3. Provide training to health care providers who work with pregnant or parenting women <br />on best practices for compliance with federal requirements that children born with <br />Neonatal Abstinence Syndrome get referred to appropriate services and receive a plan <br />of safe care. <br />4. Provide enhanced support for children and family members suffering trauma as a <br />result of addiction in the family; and offer trauma-informed behavioral health <br />treatment for adverse childhood events. <br />6
The URL can be used to link to this page
Your browser does not support the video tag.